Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxandrolone vs Megestrol Acetate for Weight Loss in Cancer Patients Receiving Chemotherapy
NCT00070148Phase 3Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxandrolone (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Lean body mass as measured by the Bioelectrical Impedance Analysis at 3 months. Started Mar 2004; status: completed.
02
Drugs
oxandrolone
Beyond the preview
Go deeper on NCT00070148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070148.